Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages

Gliomas are histologically defined as low-grade gliomas (LGG) and high-grade gliomas (HGG). The most common type of HGG is the glioblastoma (GBM). We aimed to determine the immunological characteristics of CD3 T-cells, Vδ1 T-cells, and microglia/macrophages infiltrating brain gliomas. We collected 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunologic research 2022-04, Vol.70 (2), p.224-239
Hauptverfasser: Belghali, Moulay Yassine, Admou, Brahim, Brahimi, Maroua, Khouchani, Mouna, Ba-M’hamed, Saadia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 239
container_issue 2
container_start_page 224
container_title Immunologic research
container_volume 70
creator Belghali, Moulay Yassine
Admou, Brahim
Brahimi, Maroua
Khouchani, Mouna
Ba-M’hamed, Saadia
description Gliomas are histologically defined as low-grade gliomas (LGG) and high-grade gliomas (HGG). The most common type of HGG is the glioblastoma (GBM). We aimed to determine the immunological characteristics of CD3 T-cells, Vδ1 T-cells, and microglia/macrophages infiltrating brain gliomas. We collected 24 formalin-fixed paraffin-embedded samples issued from 19 cases of GBM and 5 cases of LGG. An immunohistochemical analysis was performed using anti-CD3, anti-Vδ1, and anti-iba-1 antibodies. Labelling indexes (LI) of CD3 and Vδ1 were evaluated quantitatively, and other CD3, Vδ1, and iba-1 staining characteristics were evaluated qualitatively. The median age of patients was 49 years in GBM and 52 years in LGG. The sex ratio was 1.4 and GBM predominated in males ( p  = 0.05). In GBM, the medians of CD3-LI and Vδ1-LI were 30 and 3.5 respectively. CD3-LI inversely correlated with survival in GBM cases ( r  =  − 0.543; p  = 0.016). CD3 staining intensity correlated with CD3-LI ( p  
doi_str_mv 10.1007/s12026-022-09260-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2618514465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2638175147</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-f2fedaac6db94cab4c793647488abb123d7cace17555bf6de81114de34f5106f3</originalsourceid><addsrcrecordid>eNp9kctO3DAUhi0EgumUF2CBLLFBKun47qQ7NIWChNTNtGJnOY4zzRDbU3tSiffiOXgmPIRC1QUrH-t85z-XH4AjjD5jhOQsYYKIKBAhBaqIQAXfARPMeVUgyfkumCDCZUGkvD0AH1JaIYQFY3QfHFCOkOCsmoC7a-cGb-FmcCHqHrrOxGD9ny4G76zfwM7DZd8Fp9MX2AYzJBg8nH-ln-ACGtv36Qz-fHzA_3y1b0aZXKdnTudo_UsvbfoI9lrdJ3v48k7Bj8uLxfyquPn-7Xp-flMYKvmmaElrG62NaOqKGV0zIysqmGRlqesaE9pIo43FeUdet6KxJcaYNZaylmMkWjoFp6PuOobfg00b5bq0HU57G4akiMAlx4wJntGT_9BVGKLP02WKlrkHZjJTZKTyKilF26p17JyO9wojtbVCjVaobIV6tkJtpY9fpIfa2ea15O_tM0BHIOWUX9r41vsd2Se12pQk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638175147</pqid></control><display><type>article</type><title>Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Belghali, Moulay Yassine ; Admou, Brahim ; Brahimi, Maroua ; Khouchani, Mouna ; Ba-M’hamed, Saadia</creator><creatorcontrib>Belghali, Moulay Yassine ; Admou, Brahim ; Brahimi, Maroua ; Khouchani, Mouna ; Ba-M’hamed, Saadia</creatorcontrib><description>Gliomas are histologically defined as low-grade gliomas (LGG) and high-grade gliomas (HGG). The most common type of HGG is the glioblastoma (GBM). We aimed to determine the immunological characteristics of CD3 T-cells, Vδ1 T-cells, and microglia/macrophages infiltrating brain gliomas. We collected 24 formalin-fixed paraffin-embedded samples issued from 19 cases of GBM and 5 cases of LGG. An immunohistochemical analysis was performed using anti-CD3, anti-Vδ1, and anti-iba-1 antibodies. Labelling indexes (LI) of CD3 and Vδ1 were evaluated quantitatively, and other CD3, Vδ1, and iba-1 staining characteristics were evaluated qualitatively. The median age of patients was 49 years in GBM and 52 years in LGG. The sex ratio was 1.4 and GBM predominated in males ( p  = 0.05). In GBM, the medians of CD3-LI and Vδ1-LI were 30 and 3.5 respectively. CD3-LI inversely correlated with survival in GBM cases ( r  =  − 0.543; p  = 0.016). CD3 staining intensity correlated with CD3-LI ( p  &lt; 0.0001) and with the survival in GBM cases ( p  = 0.003). Compared to LGG, the CD3-LI, the intensity of intra-tumoral Vδ1 staining, and the amount of iba-1 were higher in GBM ( p  = 0.042; p  = 0.014; and p  = 0.001 respectively). The iba-1 organization was more amoeboid in older patients and more branched in younger patients ( p  = 0.028) and tended to be more amoeboid in cases with high iba-1 amount ( p  = 0.09). Our results suggest that a high level of CD3-LI and a strong intra-tumoral infiltration of Vδ1 T-cells as well as a high involvement of TAM can be considered potential markers of poor prognosis of GBM. However, this requires further studies on more balanced GBM-LGG sample, including an expanded panel of biomarkers.</description><identifier>ISSN: 0257-277X</identifier><identifier>EISSN: 1559-0755</identifier><identifier>DOI: 10.1007/s12026-022-09260-5</identifier><identifier>PMID: 35006549</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aged ; Allergology ; Antibodies ; Biomarkers ; Biomedical and Life Sciences ; Biomedicine ; Brain Neoplasms ; CD3 antigen ; Glioblastoma ; Glioblastoma - pathology ; Glioma ; Humans ; Immunology ; Internal Medicine ; Labeling ; Lymphocytes ; Lymphocytes T ; Macrophages ; Macrophages - pathology ; Male ; Medical prognosis ; Medicine/Public Health ; Metastases ; Microenvironments ; Microglia ; Microglia - pathology ; Middle Aged ; Original Article ; Paraffin ; Paraffins ; Sex ratio ; Staining ; Survival ; T-Lymphocytes - pathology ; Tumor Microenvironment</subject><ispartof>Immunologic research, 2022-04, Vol.70 (2), p.224-239</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-f2fedaac6db94cab4c793647488abb123d7cace17555bf6de81114de34f5106f3</citedby><cites>FETCH-LOGICAL-c375t-f2fedaac6db94cab4c793647488abb123d7cace17555bf6de81114de34f5106f3</cites><orcidid>0000-0003-4098-8992</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12026-022-09260-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12026-022-09260-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35006549$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Belghali, Moulay Yassine</creatorcontrib><creatorcontrib>Admou, Brahim</creatorcontrib><creatorcontrib>Brahimi, Maroua</creatorcontrib><creatorcontrib>Khouchani, Mouna</creatorcontrib><creatorcontrib>Ba-M’hamed, Saadia</creatorcontrib><title>Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages</title><title>Immunologic research</title><addtitle>Immunol Res</addtitle><addtitle>Immunol Res</addtitle><description>Gliomas are histologically defined as low-grade gliomas (LGG) and high-grade gliomas (HGG). The most common type of HGG is the glioblastoma (GBM). We aimed to determine the immunological characteristics of CD3 T-cells, Vδ1 T-cells, and microglia/macrophages infiltrating brain gliomas. We collected 24 formalin-fixed paraffin-embedded samples issued from 19 cases of GBM and 5 cases of LGG. An immunohistochemical analysis was performed using anti-CD3, anti-Vδ1, and anti-iba-1 antibodies. Labelling indexes (LI) of CD3 and Vδ1 were evaluated quantitatively, and other CD3, Vδ1, and iba-1 staining characteristics were evaluated qualitatively. The median age of patients was 49 years in GBM and 52 years in LGG. The sex ratio was 1.4 and GBM predominated in males ( p  = 0.05). In GBM, the medians of CD3-LI and Vδ1-LI were 30 and 3.5 respectively. CD3-LI inversely correlated with survival in GBM cases ( r  =  − 0.543; p  = 0.016). CD3 staining intensity correlated with CD3-LI ( p  &lt; 0.0001) and with the survival in GBM cases ( p  = 0.003). Compared to LGG, the CD3-LI, the intensity of intra-tumoral Vδ1 staining, and the amount of iba-1 were higher in GBM ( p  = 0.042; p  = 0.014; and p  = 0.001 respectively). The iba-1 organization was more amoeboid in older patients and more branched in younger patients ( p  = 0.028) and tended to be more amoeboid in cases with high iba-1 amount ( p  = 0.09). Our results suggest that a high level of CD3-LI and a strong intra-tumoral infiltration of Vδ1 T-cells as well as a high involvement of TAM can be considered potential markers of poor prognosis of GBM. However, this requires further studies on more balanced GBM-LGG sample, including an expanded panel of biomarkers.</description><subject>Aged</subject><subject>Allergology</subject><subject>Antibodies</subject><subject>Biomarkers</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain Neoplasms</subject><subject>CD3 antigen</subject><subject>Glioblastoma</subject><subject>Glioblastoma - pathology</subject><subject>Glioma</subject><subject>Humans</subject><subject>Immunology</subject><subject>Internal Medicine</subject><subject>Labeling</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Macrophages</subject><subject>Macrophages - pathology</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medicine/Public Health</subject><subject>Metastases</subject><subject>Microenvironments</subject><subject>Microglia</subject><subject>Microglia - pathology</subject><subject>Middle Aged</subject><subject>Original Article</subject><subject>Paraffin</subject><subject>Paraffins</subject><subject>Sex ratio</subject><subject>Staining</subject><subject>Survival</subject><subject>T-Lymphocytes - pathology</subject><subject>Tumor Microenvironment</subject><issn>0257-277X</issn><issn>1559-0755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kctO3DAUhi0EgumUF2CBLLFBKun47qQ7NIWChNTNtGJnOY4zzRDbU3tSiffiOXgmPIRC1QUrH-t85z-XH4AjjD5jhOQsYYKIKBAhBaqIQAXfARPMeVUgyfkumCDCZUGkvD0AH1JaIYQFY3QfHFCOkOCsmoC7a-cGb-FmcCHqHrrOxGD9ny4G76zfwM7DZd8Fp9MX2AYzJBg8nH-ln-ACGtv36Qz-fHzA_3y1b0aZXKdnTudo_UsvbfoI9lrdJ3v48k7Bj8uLxfyquPn-7Xp-flMYKvmmaElrG62NaOqKGV0zIysqmGRlqesaE9pIo43FeUdet6KxJcaYNZaylmMkWjoFp6PuOobfg00b5bq0HU57G4akiMAlx4wJntGT_9BVGKLP02WKlrkHZjJTZKTyKilF26p17JyO9wojtbVCjVaobIV6tkJtpY9fpIfa2ea15O_tM0BHIOWUX9r41vsd2Se12pQk</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Belghali, Moulay Yassine</creator><creator>Admou, Brahim</creator><creator>Brahimi, Maroua</creator><creator>Khouchani, Mouna</creator><creator>Ba-M’hamed, Saadia</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4098-8992</orcidid></search><sort><creationdate>20220401</creationdate><title>Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages</title><author>Belghali, Moulay Yassine ; Admou, Brahim ; Brahimi, Maroua ; Khouchani, Mouna ; Ba-M’hamed, Saadia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-f2fedaac6db94cab4c793647488abb123d7cace17555bf6de81114de34f5106f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Allergology</topic><topic>Antibodies</topic><topic>Biomarkers</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain Neoplasms</topic><topic>CD3 antigen</topic><topic>Glioblastoma</topic><topic>Glioblastoma - pathology</topic><topic>Glioma</topic><topic>Humans</topic><topic>Immunology</topic><topic>Internal Medicine</topic><topic>Labeling</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Macrophages</topic><topic>Macrophages - pathology</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medicine/Public Health</topic><topic>Metastases</topic><topic>Microenvironments</topic><topic>Microglia</topic><topic>Microglia - pathology</topic><topic>Middle Aged</topic><topic>Original Article</topic><topic>Paraffin</topic><topic>Paraffins</topic><topic>Sex ratio</topic><topic>Staining</topic><topic>Survival</topic><topic>T-Lymphocytes - pathology</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belghali, Moulay Yassine</creatorcontrib><creatorcontrib>Admou, Brahim</creatorcontrib><creatorcontrib>Brahimi, Maroua</creatorcontrib><creatorcontrib>Khouchani, Mouna</creatorcontrib><creatorcontrib>Ba-M’hamed, Saadia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Immunologic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belghali, Moulay Yassine</au><au>Admou, Brahim</au><au>Brahimi, Maroua</au><au>Khouchani, Mouna</au><au>Ba-M’hamed, Saadia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages</atitle><jtitle>Immunologic research</jtitle><stitle>Immunol Res</stitle><addtitle>Immunol Res</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>70</volume><issue>2</issue><spage>224</spage><epage>239</epage><pages>224-239</pages><issn>0257-277X</issn><eissn>1559-0755</eissn><abstract>Gliomas are histologically defined as low-grade gliomas (LGG) and high-grade gliomas (HGG). The most common type of HGG is the glioblastoma (GBM). We aimed to determine the immunological characteristics of CD3 T-cells, Vδ1 T-cells, and microglia/macrophages infiltrating brain gliomas. We collected 24 formalin-fixed paraffin-embedded samples issued from 19 cases of GBM and 5 cases of LGG. An immunohistochemical analysis was performed using anti-CD3, anti-Vδ1, and anti-iba-1 antibodies. Labelling indexes (LI) of CD3 and Vδ1 were evaluated quantitatively, and other CD3, Vδ1, and iba-1 staining characteristics were evaluated qualitatively. The median age of patients was 49 years in GBM and 52 years in LGG. The sex ratio was 1.4 and GBM predominated in males ( p  = 0.05). In GBM, the medians of CD3-LI and Vδ1-LI were 30 and 3.5 respectively. CD3-LI inversely correlated with survival in GBM cases ( r  =  − 0.543; p  = 0.016). CD3 staining intensity correlated with CD3-LI ( p  &lt; 0.0001) and with the survival in GBM cases ( p  = 0.003). Compared to LGG, the CD3-LI, the intensity of intra-tumoral Vδ1 staining, and the amount of iba-1 were higher in GBM ( p  = 0.042; p  = 0.014; and p  = 0.001 respectively). The iba-1 organization was more amoeboid in older patients and more branched in younger patients ( p  = 0.028) and tended to be more amoeboid in cases with high iba-1 amount ( p  = 0.09). Our results suggest that a high level of CD3-LI and a strong intra-tumoral infiltration of Vδ1 T-cells as well as a high involvement of TAM can be considered potential markers of poor prognosis of GBM. However, this requires further studies on more balanced GBM-LGG sample, including an expanded panel of biomarkers.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>35006549</pmid><doi>10.1007/s12026-022-09260-5</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0003-4098-8992</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0257-277X
ispartof Immunologic research, 2022-04, Vol.70 (2), p.224-239
issn 0257-277X
1559-0755
language eng
recordid cdi_proquest_miscellaneous_2618514465
source MEDLINE; SpringerLink Journals
subjects Aged
Allergology
Antibodies
Biomarkers
Biomedical and Life Sciences
Biomedicine
Brain Neoplasms
CD3 antigen
Glioblastoma
Glioblastoma - pathology
Glioma
Humans
Immunology
Internal Medicine
Labeling
Lymphocytes
Lymphocytes T
Macrophages
Macrophages - pathology
Male
Medical prognosis
Medicine/Public Health
Metastases
Microenvironments
Microglia
Microglia - pathology
Middle Aged
Original Article
Paraffin
Paraffins
Sex ratio
Staining
Survival
T-Lymphocytes - pathology
Tumor Microenvironment
title Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A29%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20tumoral%20microenvironment%20in%20gliomas:%20focus%20on%20CD3+%20T%20cells,%20V%CE%B41+%20T%20cells,%20and%20microglia/macrophages&rft.jtitle=Immunologic%20research&rft.au=Belghali,%20Moulay%20Yassine&rft.date=2022-04-01&rft.volume=70&rft.issue=2&rft.spage=224&rft.epage=239&rft.pages=224-239&rft.issn=0257-277X&rft.eissn=1559-0755&rft_id=info:doi/10.1007/s12026-022-09260-5&rft_dat=%3Cproquest_cross%3E2638175147%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638175147&rft_id=info:pmid/35006549&rfr_iscdi=true